Mark Schoenebaum

Director, TG Therapeutics.

Companies

Immunovant, Inc.Board member May 9, 2019 to May 9, 2019¹
TG TherapeuticsBoard member Apr 27, 2012 to Jun 28, 2018²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARImmunovant, Inc., Board member
2
SEC EDGARTG Therapeutics, Board member